Abstract Caspase activation and degradation of deoxyribonucleic acid (DNA) damage response factors occur during in vitro T-cell proliferation, and an increased frequency of hypoxanthine-guanine phosphoribosyltransferase (HPRT)-negative variants have been reported in conditions associated with in vivo T-cell proliferation. We have applied two human somatic cell mutation reporter assays, for the HPRT and phosphatidylinositol glycan class A (PIG-A) genes, to human T cells activated in vitro with anti-CD3 and anti-CD28. We demonstrate proliferation throughout 6 weeks of cultivation, and find that the frequency of variant cells phenotypically negative for HPRT and PIG-A, respectively, increases from 10 −5 up to 10 −3 -10 −2 . We also report preliminary evidence for lowdensity CpG methylation in the HPRT promoter suggesting that epigenetic modification may contribute to this markedly heightened rate of gene inactivation.
Introduction
Signs of deoxyribonucleic acid (DNA) damage response (DDR) deficiency have been observed in cells undergoing rapid proliferation, including inactivation of the p16 cell cycle inhibitory gene in normal breast epithelia (Romanov et al. 2001; Sancar et al. 2004) . Furthermore, lymphocyte proliferation is coupled with partial caspase activation leading to degradation of DDR factors (Alam et al. 1999; Chun et al. 2002; Miossec et al. 1997; Newton and Strasser 2003; Tong et al. 2001) , and with production of DNAdamaging reactive oxygen species (ROS) (Hildeman et al. 2003; Martindale and Holbrook 2002 ). An elevated frequency of variant cells in conditions associated with strong lymphocyte activation has been revealed by the hypoxanthine-guanine phosphoribosyltransferase (HPRT) standard human mutation reporter assay (Albertini 2001; Ansari et al. 1995; Gmelig-Meyling et al. 1992) . However, the mutation rate in proliferating lymphocytes may then have been underestimated, as activated T cells are highly susceptible to 'activation-induced' cell death (Abbas 1996; Hildeman et al. 2002 Hildeman et al. , 2003 , and thus may not survive the in vitro 1-to-2-week cloning step.
The present work was initiated to test if an increased mutation rate is one of the numerous changes, including activation of immune-response genes, that occur during lymphocyte proliferation (Chtanova et al. 2005) . We have determined the fraction of T cells showing loss of HPRT or glycosylphosphatidylinositol (GPI) function, using flow cytometry analysis with no need for cell cloning. HPRT mediates the incorporation into DNA of the 6-thioguanine (6TG) base analogue leading to DNA replication arrest, and loss of HPRT can therefore be defined by DNA synthesis occurring in the presence of this cytotoxic drug (Kotova and Grawe 2002) . A GPI anchor is required for attachment of CD52 and CD59 to the cell surface, permitting a loss of GPI to be measured by analysis of these CD markers (Araten et al. 1999; Takeda et al. 1993 ). We now demonstrate a more than 100-fold rise in the fraction of variant cells negative for HPRT and GPI, respectively, during several weeks of in vitro human T-cell proliferation. Although DNA sequencing for determination of the mutational status of cloned variant cells was not performed, we provide preliminary evidence that gene promoter CpG methylation contributes to this high rate of gene inactivation during T-cell proliferation.
Materials and methods

Reagents
The following antibodies were used: anti-CD28 (clone YTH 913.12), anti-caspase 3 (AHP476, recognizing intact 32 kDa and the 17 kDa, but not 11 kDa, fragment), anti-DFF (clone AHP433, recognizing the intact 45 kDa form and two C-terminals approximately 10-and 30-kDa fragments) (Liu et al. 1997 ), PE-anti-CD52 and negative controls (Serotec, Oxford, UK); flourescein isothiocyanate (FITC)-anti-CD44, FITC-anti-CD18, PE-anti-CD59 and negative controls (Immunotech, Marseille, France); anti-CD3 (clone UCHT1, BD Biosciences); anti-BrdU and its secondary FITC-conjugated antibody as well as secondary horseradish peroxidase (HRP)-conjugated antibodies (DAKO, Cambridgeshire, UK). Interleukin-2 (IL-2) was from Roche, 5,6-carboxyfluorescein succinimidyl ester (CFSE) from Molecular Probes, phytohaemagglutinine (PHA) from Murex (Wiesbaden, Germany), 6-thioguanine (6TG) from Sigma (St. Louis, MO, USA).
T-cell culture Peripheral blood mononuclear cells were isolated from venous blood of healthy donors and a patient with paroxysmal nocturnal haematuria (PNH) by gradient centrifugation (Lymphoprep, Nycomed, Oslo, Norway) , and cultured at 10 6 cells/ml in 5% CO 2 at 37°C. Cell density was kept at <2×10 6 cells/ml by dilution with IL-2-containing medium as appropriate. PHA (1 μg/ml) or culture flasks precoated with anti-CD3/anti-CD28 (1:1 mixture of 10 μg/ml) was used for stimulation. IL-2 at final concentration of 10 U/ ml was added at day 3. After 2-4 weeks of culture, at signs of slown growth and increased death, restimulation by transfer to a precoated (as above) flask was done.
Western blot Protein extracts were prepared and sodium dodecyl sulfate (SDS) gel electrophoresis and blotting was done as described (Sallmyr et al. 2001) . Enhanced chemiluminescene (ECL) (Amersham-Pharmacia) and either X-ray film or a BioRad Personal Molecular Imager FX was used for detection of the peroxidase-conjugated secondary antibodies.
Thymidine incorporation Cultured T cells were stimulated as described above and cultivated in a 96-well plate in triplicate in growth medium at 10 6 cells/ml. At day 5 the wells were pulsed for 20 h with [ 3 H]-labeled thymidine (Amersham, 25 Ci/mmol, 0.5 μCi/well) and counted using a 1450 MicroBeta Trilux, Wallac.
CFSE staining CFSE analysis was done as described (Lyons and Parish 1994) . This dye is deacetylated intracellularly to a non-diffusible fluorescent derivative, which can be determined by flow cytometry. In brief, 5× 10 6 of cells/well in six-well plates were aliquoted in growth medium, incubated with CFSE (1 μM) for 30 min at 37°C, washed three times with phosphate-buffered saline (PBS), and analysed by flow cytometry (FACSCalibur from BD). Every day cells from the next well were analysed.
GPI flow cytometry assay T cells were stained with FITCconjugated anti-CD18 and anti-CD44 and PE-conjugated anti-CD52 and anti-CD59, and then analysed by flow cytometry (Araten et al. 1999) . To determine the location of viable cells lacking GPI protein, labeling was done with only the FITC-conjugated antibodies, but omitting anti-CD52 and anti-CD59. In so doing, a region for cells lacking phosphatidylinositol glycan class A (PIG-A) gene expression was defined (Fig. 2a) . Data analysis and plotting were done using WinList (Verity Software, Topsham, ME, USA).
HPRT flow cytometry assay A modified method for analysis of HPRT-deficiency with no cloning of mutant cells was used (Kotova and Grawe 2002) . T cells were grown in the presence of 6TG during the final 20 h, and BrdU was present at 10 −5 M during the last 6 h. A nuclei preparation was incubated with anti-BrdU and a secondary FITC-conjugated antibody, and labeled with propidium iodide (PI). FL-1 (FITC) and FL-3 (PI) fluorescence signals were collected, and the doublet discrimination module (Cellquest software, BD) was used to exclude false positive events resulting from cell aggregates (by using pulse width) or from dead cells (by using pulse height). The variant cell frequency (VF) was calculated as described (Kotova and Grawe 2002) . For example, in Fig. 3 Bisulfite DNA sequencing DNA was bisulfite-modified using the EZ DNA Methylation-Gold Kit (Zymo Research). A promoter region was amplified by polymerase chain reaction (PCR) as described below, the PCR product was cloned (TopoTA cloning kit, Invitrogen) and submitted to the local sequencing core facility for Applied Biosystems (ABI) sequencing.
PCR Primers were designed based on the HPRT 5′-flanking regions given on the University of California at Santa Cruz website http://genome.ucsc.edu, to bind nonCpG sequences and give products irrespective of the template's CpG methylation status. Two forward primers binding to sequences 155 bp apart were used in separate PCR amplifications: 5′-GTTAGGAAAATGGAAGTTA TAGGTA and 5′-ATTGAGTTGGGAGGGAAAGG; for all clones the reverse primer was 5′-CCATTTC CACCTTCTCTTCCCA. Cycling conditions were 95°C for 12 min followed by 40 cycles of 95°C for 1 min, 58°C for 1 min 30 s, 72°C for 2 min 30 s, and then 72°C for 10 min. The 25-μl reaction solution contained 0.2 μM each primer, 0.1 unit Hotstar Taq polymerase (Qiagen), 1.5 mM MgCl 2 , 200 μM each deoxyribonucleotide triphosphate (dNTP) and 2 μl of the bisulfite-modified DNA. For all PCR reactions, only the bisulfite-modified sense strand was amplified, starting with the reverse primer binding to this sense strand, and the complementary molecule thus produced serving as template for the forward primer.
Results
T-cell activation and long-term proliferation with caspase 3 activation Similar DNA synthesis activities, as measured by 3 H-thymidine incorporation, were seen at culture day 6 in the presence of PHA or monoclonal antibodies to CD3 and CD28, but the total number of viable cells was slightly higher for the antibody combination, as compared with PHA (8.8-and 6.5-fold increase, respectively). The fraction of dead cells, as determined by trypan blue dye exclusion, was lower for anti-CD3/anti-CD28 (<2%, and 10% for PHA). It has been shown that cellular CFSE content can be reduced by a factor of two per cell division, permitting the tracking of at least five ensuing cell cycles. Already on the third day after in vitro stimulation, some cells presented with a reduced CFSE signal (left peak of Fig. 1a) . The double peak pattern generated by brightly CFSE-positive day 0 cells (solid line on right side of Fig. 1a ) was seen only at culture start, and may reflect the presence of many mononuclear cell types.
Flow cytometry revealed minor fractions of CD19+ B cells and CD14+ monocytes at culture start, whereas from the end of the first week and onwards only CD3+ T cells could be detected. The culture was again labelled with CFSE at day 9. Reduction of CFSE content was observed over days 10, 11 and 12, demonstrating proliferation apparently in the entire viable population and suggesting a generation time of approximately 24 h (Fig. 1b) . At week 4 a halt in proliferation was indicated by the closely located peaks at days 22-24 (Fig. 1c) . This was seen in all cultures between 2 and 4 weeks after stimulation. The right-side, high intensity peak seen at CFSE staining on day 22 may reflect artefactual and strong binding of dye to aggregated material derived from dead cells, becoming lost at the ensuing dates. Proliferation was resumed after restimulation with anti-CD3/anti-CD28, with CFSE results at days 30-32 not different from the earlier weeks (Fig. 1d) . Throughout the culture periods of 5-6 weeks viability was high with less than 2% trypan blue non-excluding cells, except for 5-50% dead cells during slowed growth.
Partial activation of the apoptosis caspase cascade is a component of normal T-cell activation (Newton and Strasser 2003) . Stimulation with anti-CD3/anti-CD28 was accompanied by degradation of procaspase 3 into its active 17-kDa fragment (Fig. 2e) , but with no sign of formation of <45 kDa active DNA fragmentation factor (DFF) (Fig. 2f) . The minor 17 kDa caspase 3 band seen at culture start may reflect the in vivo activated human leukocyte antigen (HLA) class II-positive T cells routinely seen (1-10% of total T cells) in healthy donors. The intensity of the barely detectable bands corresponding to degraded DFF forms show intensity covariation with the intact form, and cannot be interpreted as DFF activation.
PIG-A gene inactivation during proliferation PIG-A gene inactivation leads to loss of the GPI membrane protein, acting as an anchor for a number of lymphocyte surface proteins, e.g. CD52 and CD59. T cells were labelled with antibodies to CD18/CD44 (but not with the antibodies to CD52/CD59) to identify the dot-plot location (R2) of cells lacking GPI-anchored CD52/CD59, but with normal expression of the GPI-independent CD18/CD44 (Fig. 2a) . Results from representative experiments are included in Fig. 2a-d , showing a relatively low variant cell frequency at culture start (<1×10 −4 at day 0) (Fig. 2b) ; to become markedly increased at culture day 10 (47×10 −4 ) (Fig. 2c); later to return to a lower level (<0.1×10 −4 at day 42) (Fig. 2d) . Analysis of cells from a patient diagnosed with PN verified the capacity of our method to detect PIG-Amutant cells, showing a large amount of CD52/CD59-negative lymphocytes (16%) (results not shown). In another control experiment a normal donor lymphocyte sample was spiked with decreasing numbers of PNH lymphocytes, documenting the method's capacity to detect rare PIG-A variant cells (Table 1 ). All the performed T-cell cultures showed a peak in the frequency of GPI-negative cells during weeks 2-5, as depicted by the plotting of all determinations made with >10 5 cells (Fig. 2e) . For two of the cultures analysed at >2 time points the documented increase amounted to a 1,000-fold or higher, for example from a starting level of 0.04×10 −4 to 44×10 −4 .
HPRT gene inactivation during proliferation Proliferating lymphocytes were incubated with 6TG for 20 h at culture end and with the DNA-specific BrdU base analogue during the last 6 h of these 20 h. Cell nuclei were stained with propidium iodide (PI) (to measure total DNA content) and with FITC-labelled anti-BrdU (to define cells located in S phase). Only cells in late S phase were scored, as some label may be incorporated by HPRT-positive cells into newly synthesised DNA in the presence of 6TG (Albertini 2001) . A representative flow cytometry experiment is shown in Fig. 3 . Approximately 10% of the non-6TG-treated control cells were located in late S phase, as defined by the square R3 region of Fig. 3 , left panel.
In the presence of 6TG, lymphocytes from culture day 7 showed a relatively high frequency of late S phase, i.e. HPRT-negative cells (9.5×10 −4 ) (Fig. 3, middle panel) . The majority of these events can be regarded to truly represent BrdU-incorporating cells. However, a control experiment in the absence of the BrdU base analogue also revealed some events in the R3 region, representing cells non-specifically labelled with FITC-anti-BrdU (Fig. 3, right panel) . The true HPRT-negative variant cell frequency in Fig. 3a is therefore given by 9.5-2.7=6.8×10 Cell number CFSE fluorescence intensity Fig. 1 Partial caspase 3 activation and reduction in CFSE fluorescense intensity, verifying activation and long-term proliferation among a majority of the T lymphocytes. Cells were stimulated with anti-CD3/ anti-CD28 and stained with CFSE at a day 0, b day 9, c day 22, d day 30. Solid lines denote the staining day and dotted lines the nextcoming dates. Protein was extracted at the indicated culture times, immunoblotted with e anti-caspase 3 (recognizing the full-length 32-kDa form and the active caspase 17-kDa derivative) or f anti-DFF (recognizing the full-length 45-kDa form and derivatives resulting from caspase cleavage). 6TG was added to the cultures of lanes 3 and 5 at 20 h before protein extraction (6TG inhibits proliferation of HPRT-expressing cells and is used for the detection of HPRT variants). The results are from representative cultures frequency could not be assessed for HPRT, due to the S phase basis of the method (for culture day 0 data, see the PIG-A gene results).
However, a decline was found at culture day 42, with no detectable HPRT-negative cells as determined by specific events in the late S-phase gate. Cultures from two other healthy donors showed VF peaks of 17.2× 10 −4 at day 36 and 34.1×10 −4 at day 23 (results not shown). For comparison, it may be of interest to note that although fewer experiments were made with the HPRT method, and although no day 0 value could be obtained with HPRT, the results suggested a similar kinetic pattern as with GPI, as well as a similar gene inactivation frequency level.
Analysis of CpG methylation in the HPRT promoter region HPRT expression is regulated by a CpG-rich promoter (Holliday and Ho 2002; Kang et al. 2003) . Due to the X chromosome location of HPRT and its housekeeping function, human cells in general carry one active allele. However, which CpGs are most important for the control of HPRT gene expression has not been clearly established. We have studied a 386-bp region upstream of the coding sequence with a total of 39 CpG sites and several Note that Y-axis uses log scale transcription factor-binding motifs including four GGGCGG Sp1 sites. A gene regulatory function is further suggested by a division of this segment based on CpG site clusters. This reveals some subregions with a marked homology with the corresponding mouse sequence (up to 78%, as compared with 25% in the most 5′ 120-bp portion) (Fig. 4) .
After DNA bisulfite modification, the promoter region was PCR-amplified, cloned and sequenced. Two different upstream PCR primers were used, explaining why only 14 clones include results for the 5′ 12 CpGs (Fig. 4) . More methylation was seen in the 12 low-homology subregion CpGs, as compared with CpG's 13-39 (highly significant, with chi-square 105.6), but with no significant difference between proliferating (28.7%) and resting cells (21.7%). The frequency of methylated CpGs in the high-homology segment (CpG's 13-39) in 11 clones analysed from proliferating T cells (3.0%) was higher than in 11 clones from unstimulated cells (1.3%); however, no statistic significance was reached (chi-square 1.3). Four methylated CpG sites (i.e. 44% of the total of nine) were detected in proliferating T cells within the highest homology (78%) subregion representing only four of the total 27 CpG sites (=15%) and 23 of the total 266 bp (=9%), indicating preferential seeding of methylation in gene-regulatory sequences during proliferation.
Discussion
A generation time as short as 6 h is observed during the limited proliferation phase of human lymphocyte activation in vivo (Abbas and Lichtman 2003) . It can be speculated that a restricted use of DNA damage responses such as cell cycle arrest confers a selective advantage by reducing the time needed to build up clones of effector cells large enough for the host to survive a microbial attack. Danger for the host in terms of malignant transformation may then be negligible, as physiologic activation-induced cell death will follow as soon as immune effector mission has been completed (Hildeman et al. 2002) .
In the present work we test the idea that reduced DDR combined with an increase in DNA damage during physiologic T-cell activation will increase the basal mutation rate. A mutated cell is then probably strongly programmed for apoptosis and therefore may not get through a week-long in vitro cloning procedure, suggesting that the current HPRT methodology is unable to document an elevated mutation rate during T-cell activation in vitro. Therefore, we have employed two recently published phenotypic flow cytometric methods for measurement of HPRT and PIG-A gene expression, with no need for cell cloning of mutants. Our finding of up to a 1,000-fold increase in variant cell frequency cannot be explained solely by the spontaneous mutation rate acting over many cell divisions. A simple calculation shows that the number of cell divisions occurring in our T-cell cultures, in combination with the normal basal mutation rate during proliferation of 10 −6 /cell/ generation (Albertini 2001; Drake et al. 1998; Tomlinson et al. 1996) , will cause less than a twofold increase in mutation frequency.
, with M, mutation frequency; t, number of cell generations; a, M at culture start; b, basal spontaneous mutation rate. For example, assuming a mutation frequency of 10 −5 at culture start, the spontaneous mutation rate acting over 30 cell generations will yield a mutation frequency of 2.5×10 . Therefore, our data indicate a marked increase not only in mutation frequency but also in the rate of some mechanism of gene inactivation. It should be noted that no selective drug was present during our 6-week cultures, providing no basis for preferential outgrowth of preformed variant cells; in contrast, the CFSE data indicate that the majority of the T cells were proliferating. It can be speculated that the return The base positions relative to the HPRT mRNA start site are shown. Promoter subregions are defined by closely located groups of CpG sites, revealing variation in human-mouse sequence homology, and suggesting that the upstream 12-CpG-site subregion (with 25% homology) is less likely to be a gene expression regulatory sequence, as compared with the remaining 27-CpG site at a late culture time point to a low variant level is due to a relatively marked apoptotic disposition of a strongly proliferative and mutated T-cell subpopulation. It is unlikely that our variant frequency data are artefactual and represent the non-viable fraction of cells constantly present in lymphocyte cultures. First, the trypan blue dye exclusion test showed no increase in cell death at culture time points with a high variant level. Second, all results were collected only from flow cytometry events presenting with normal light forward and side scattering, considered to be characteristics of viable cells. Third, and foremost, both assays require a cell to display signs of intact homeostasis for it to be scored as a variant; HPRT variants show duplicated total DNA content and newly replicated DNA; GPI variants show normal cell surface density of two GPI-independent proteins, CD18 and CD44. However, we may possibly have somewhat underestimated the true variant frequency because of HPRT or GPI protein remaining at sufficiently high concentration in the T cells for a few generations after gene inactivation, for the cell to escape from becoming scored as a mutant. A gradual loss of GPI protein during the cell generations after the PIG-A gene inactivation can also explain the flow cytometry dot plot 'tail' shape of the GPI-deficient cells (Fig. 2c) .
Can we point to any plausible cellular mechanism(s) for generation of the large populations of variant lymphocytes? DNA-damaging and potentially mutagenic ROS (Laval et al. 1997; Martindale and Holbrook 2002) are present at elevated quantities during cell proliferation, and they are implicated in the massive death of lymphocytes initiated after the effector phase (Hildeman et al. 2003) . Another candidate mechanism is programmed down-regulation of genomic surveillance. This has been suggested to be a general feature of terminally differentiated cells (Nouspikel and Hanawalt 2002) and has been observed in rare HPRTnegative T-cell clones (Albertini 2001; Finette et al. 2000) . Among the DDR factors becoming degraded in activated T cells is poly(ADPribose) polymerase (PARP), named guardian of the genome and considered to require large adenosine triphosphate (ATP) quantities for its polyadenylation during DNA single-strand break repair (de Murcia and Shall 2000) . In addition, induction of mutagenic cellular factors may form part of such programming, including illegitimate expression of V(D)J recombinase (Lipkowitz et al. 1992; McGregor et al. 1994; Meydan et al. 1998) , and production of a highly mutagenic cytosine deaminase (Bhagwat 2004) .
The HPRT and PIG-A reporter assays have been verified to truly reflect DNA mutations (Albertini 2001; Araten et al. 1999 ), but HPRT promoter CpG methylation can also lead to formation of HPRT variant cells (Holliday and Ho 2002) , documenting epigenetic modification as a possible basis for our observation of HPRT deficient T cells.
Although our epigenetic results revealed no signs of cells with a densely methylated HPRT promoter suggestive of gene silencing, it should be noted that our PCR cloning strategy was not sensitive enough to detect variant cell frequencies of 1/1,000 or less. Recently, two groups have presented evidence for a 'seeding' two-step mechanism operating during epigenetic gene silencing (Stirzaker et al. 2004; Ushijima 2005) . The first step involves low-density methylation in a high fraction of the cells, similar to that we have observed for HPRT, while the second step with highdensity promoter methylation and gene inactivation occurs only in a few of the 'seeded' cells. These reports support that our findings of sparse methylation may reflect a mechanism for gene silencing in activated T cells. Future work will be needed to decipher the molecular event(s) behind the extensive gene inactivation we observed in proliferating T cells.
